Tech Company Financing Transactions

Forge Therapeutics Funding Round

MagnaSci Ventures, Alexandria Venture Investments and MP Healthcare Venture Management participated in a $15 million Series A venture round for Forge Therapeutics. The financing was announced by the company on 4/26/2017.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

10578 Science Center Dr. 205
San Diego, CA 92121
USA

Phone

Undisclosed

Website

www.forgetherapeutics.com

Email Address

[email protected]

Overview

Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. Forge has developed a fundamentally new approach for the discovery of metalloprotein inhibitors by focusing first on the metal in the enzyme active site.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Zachary Zimmerman

        

Chief Financial Officer

Esther Boom

        

Chief Operating Officer

David Puerta

        

Vice President

Min Teng

        

Browse more venture capital transactions:

Prev: 4/26/2017: Sense360 venture capital transaction
Next: 4/26/2017: Kidfresh venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to document every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary